Wellington Management Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.25M | Sell |
|
|||||
|
2024
Q3 | $2.31M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $376K | Sell |
|
|||||
|
2023
Q4 | $3.95M | Sell |
|
|||||
|
2023
Q3 | $12.4M | Buy |
|
|||||
|
2023
Q2 | $26.5M | Sell |
|
|||||
|
2023
Q1 | $36.8M | Sell |
|
|||||
|
2022
Q4 | $23.9M | Buy |
|
|||||
|
2022
Q3 | $8.98M | Sell |
|
|||||
|
2022
Q2 | $4.76M | Sell |
|
|||||
|
2022
Q1 | $6.72M | Sell |
|
|||||
|
2021
Q4 | $17M | Sell |
|
|||||
|
2021
Q3 | $33.9M | Sell |
|
|||||
|
2021
Q2 | $82.1M | Sell |
|
|||||
|
2021
Q1 | $79.3M | Sell |
|
|||||
|
2020
Q4 | $92.6M | Sell |
|
|||||
|
2020
Q3 | $89.6M | Sell |
|
|||||
|
2020
Q2 | $91.7M | Sell |
|
|||||
|
2020
Q1 | $83.3M | Sell |
|
|||||
|
2019
Q4 | $93.9M | Buy |
|
|||||
|
2019
Q3 | $70.3M | Sell |
|
|||||
|
2019
Q2 | $74M | Sell |
|
|||||
|
2019
Q1 | $90.5M | Buy |
|
|||||
|
2018
Q4 | $86.8M | Buy |
|
|||||
|
2018
Q3 | $99.8M | Buy |
|
|||||
|
2018
Q2 | $104M | Sell |
|
|||||
|
2018
Q1 | $117M | Buy |
|
|||||
|
2017
Q4 | $128M | Buy |
|
|||||
|
2017
Q3 | $64.5M | Buy |
|
|||||
|
2017
Q2 | $51.2M | Sell |
|
|||||
|
2017
Q1 | $43.5M | Sell |
|
|||||
|
2016
Q4 | $44.5M | Sell |
|
|||||
|
2016
Q3 | $39.1M | Buy |
|
|||||
|
2016
Q2 | $31.8M | Buy |
|
|||||
|
2016
Q1 | $28.8M | Buy |
|
|||||
|
2015
Q4 | $17.8M | Buy |
|
|||||
|
2015
Q3 | $2.66M | Sell |
|
|||||
|
2015
Q2 | $3.47M | Buy |
|
|||||
|
2015
Q1 | $2.23M | Sell |
|
|||||
|
2014
Q4 | $2.71M | Buy |
|